CN109678739B - Synthetic method of R-3-chloroserine methyl ester hydrochloride - Google Patents

Synthetic method of R-3-chloroserine methyl ester hydrochloride Download PDF

Info

Publication number
CN109678739B
CN109678739B CN201811613850.3A CN201811613850A CN109678739B CN 109678739 B CN109678739 B CN 109678739B CN 201811613850 A CN201811613850 A CN 201811613850A CN 109678739 B CN109678739 B CN 109678739B
Authority
CN
China
Prior art keywords
methyl ester
chloroserine
ester hydrochloride
serine
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811613850.3A
Other languages
Chinese (zh)
Other versions
CN109678739A (en
Inventor
王丹
杨文�
李军
张新伟
刘丽莉
袁志法
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Sinopharm International Corp
Original Assignee
China Sinopharm International Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Sinopharm International Corp filed Critical China Sinopharm International Corp
Priority to CN201811613850.3A priority Critical patent/CN109678739B/en
Publication of CN109678739A publication Critical patent/CN109678739A/en
Priority to PCT/CN2019/103059 priority patent/WO2020134137A1/en
Application granted granted Critical
Publication of CN109678739B publication Critical patent/CN109678739B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38Separation; Purification; Stabilisation; Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the field of drug synthesis, and discloses a synthesis method of R-3-chloroserine methyl ester hydrochloride, which comprises the following steps: adding paraformaldehyde into D-serine, reacting at room temperature, and crystallizing in a small volume to obtain D-serine NCA; adding thionyl chloride into the D-serine NCA in methanol, reacting at room temperature, and adding petroleum ether to obtain R-3-chloroserine methyl ester hydrochloride. The method has the advantages of simple process operation, environment friendliness, mild reaction conditions, high purity of the final product up to 99 percent, high yield up to 94.72 percent and contribution to industrial production.

Description

Synthetic method of R-3-chloroserine methyl ester hydrochloride
Technical Field
The invention relates to the field of drug synthesis, and relates to a preparation method of R-3-chloroserine methyl ester hydrochloride.
Background
The antibiotic is a secondary metabolite of a class which is generated by microorganisms (including bacteria, fungi and actinomycetes) or higher animals and plants in the living process and has anti-pathogen or other activities, and a chemical substance which can interfere the development function of other living cells, the antibiotics which are commonly used in clinic comprise genetically modified engineering bacteria, extracts in culture solution and chemically synthesized or semisynthetic compounds, the cycloserine, also called D-4-amino-3-oxazolidinone, is an antibiotic drug and has good inhibiting effect on tubercle bacillus, and the D-cycloserine is a special regulating factor of excitatory amino acid (N-methyl-D-aspartate) receptors in the central nervous system and has good auxiliary curative effect on treating psychological diseases such as psychological phobia, depression and schizophrenia, and the like, and the D-cycloserine is an important intermediate of synthesizing atypical β -lactam antibiotic Lactivin, and has wide market application prospect.
The existing synthetic route of the cycloserine is mainly synthesized by the following routes:
the synthetic route is as follows (US2772280, US2772281, US2640565, US2794022, US2918472 and the research on the chemical synthesis process of cycloserine, journal of Wassi pharmacy, 1995,10 (1): 39-39): the route has long steps, needs to be split, and has higher synthesis cost.
Figure BDA0001925414960000011
GB 1031267 reports a preparation method of D-cycloserine by using β - (α ' -ethoxyethylene) -aminoxy- α -bromomethyl propionate as a raw material, wherein β - (α ' -ethoxyethylene) -aminoxy- α -bromomethyl propionate is aminated under the action of liquid ammonia to generate β - (α ' -ethoxyethylene) -aminoxy- α -aminopropionamide, then β -aminoxy-alaninamide dihydrochloride is obtained after HCl gas treatment, DL-cycloserine is generated by cyclization under the action of KOH, and finally D-cycloserine is obtained by splitting with tartaric acid.
The preparation method of D-cycloserine by using D-1-triphenylmethyl aziridine-2-methyl formate as raw material is reported in GB 854922. D-1-triphenylmethyl aziridine-2-methyl formate firstly reacts with hydroxylamine hydrochloride at room temperature to generate D-1-triphenylmethyl aziridine-2-hydroxamic acid, then the D-1-triphenylmethyl aziridine-2-hydroxamic acid is subjected to ring opening under the action of HCl gas to generate D- α -amino- β -chloropropyl hydroxamic acid hydrochloride, and the D-cycloserine is prepared by ring opening under the action of strong-base anion exchange resin.
PlttenerP.A. et al propose a simple method for synthesizing D-cycloserine using D-serine methyl ester hydrochloride as a raw material. Namely, the D-serine methyl ester hydrochloride (1) and phosphorus pentachloride are subjected to chlorination reaction to generate D-2-amino-3-chlorolactamic acid methyl ester hydrochloride (II), the II and hydroxylamine are cyclized in sodium hydroxide solution to generate D-ring serine (I), and the cyclization yield is 40%. The synthetic route is shown as the following formula:
Figure BDA0001925414960000021
the method uses expensive D-serine methyl ester hydrochloride as raw material, has high cost, uses a large amount of PCl5 which is difficult to treat in the production process, and causes serious pollution to the environment.
R-3-chloroserine methyl ester hydrochloride is an important intermediate of cycloserine, and the synthesis of R-3-chloroserine methyl ester hydrochloride is not reported at home and abroad. In order to overcome the defects of expensive raw materials, low purity, low yield and environmental pollution of the existing D-cycloserine synthesis technology, the application provides a new route of R-3-chloroserine methyl ester hydrochloride, the reactions are all conventional operations, and the operation is simple and convenient; and the raw materials are all sold in the market, the price is proper, the supply is sufficient, and the industrial prospect is better.
Disclosure of Invention
Based on the technical problems in the background art, the invention provides the R-3-chloroserine methyl ester hydrochloride, and the method has the advantages of low cost, low environmental pressure, high yield and contribution to large-scale production.
A synthetic method of R-3-chloroserine methyl ester hydrochloride is characterized by comprising the following steps:
1) synthesis of D-serine-N-carboxyanhydride: adding polyformaldehyde into D-serine, reacting at room temperature for 0.5-3 hours, recovering the solvent, and crystallizing to obtain D-serine-N-carboxyl acid anhydride (D-serine NCA);
2) synthesis of R-3-chloroserine methyl ester hydrochloride: adding D-serine NCA into a solvent, adding thionyl chloride, reacting at 15-25 ℃ for 1-3 hours, recovering the solvent, and adding petroleum ether for crystallization to obtain R-3-chloroserine methyl ester hydrochloride.
Preferably, the molar ratio of D-serine to paraformaldehyde in the reaction is 1: 1.2-1.5.
Preferably, the molar ratio of the D-serine NCA to the thionyl chloride to the petroleum ether in the reaction is 1: 1.5-2.0: 1.
preferably, the solvent in step 1) is anhydrous tetrahydrofuran or dichloromethane.
Preferably, the solvent in step 2) is methanol or ethanol.
The synthetic route of the invention is as follows:
(1)
Figure BDA0001925414960000031
(2)
Figure BDA0001925414960000032
compared with the prior art, the invention has the beneficial effects that:
r-3-chloroserine methyl ester hydrochloride is an important intermediate of cycloserine, synthesis of R-3-chloroserine methyl ester hydrochloride is not reported at home and abroad, and hydroxyl is not easily substituted in the cyclization process, so the intermediate is not used in the prior art. Compared with the existing cycloserine synthesis intermediate, the invention provides a synthesis method of R-3-chloroserine methyl ester hydrochloride, NCA is formed in the step 1), hydroxyl is easier to be substituted, and R-3-chloroserine methyl ester hydrochloride is easy to prepare, so that higher yield is obtained, the method is suitable for industrial production, has high purity, and has direct influence on the yield of cycloserine; meanwhile, the method avoids the use of a large amount of PCl5 or acyl chloride reagents in the existing cycloserine synthesis technology, and is more environment-friendly; and (3) ending the process, filtering to remove salt, and concentrating to obtain the product, wherein the process is simple, the industrialization is easier, the purity of the final product is as high as 99%, and the yield is as high as 94.72%.
Detailed Description
The present invention will be further illustrated with reference to the following specific examples.
Figure BDA0001925414960000041
Example 1
1) Adding 108g of paraformaldehyde into 105g of D-serine in 500ml of tetrahydrofuran, reacting at room temperature for 2 hours, recovering the tetrahydrofuran, and crystallizing to obtain D-serine NCA in a small volume;
2) adding 110mL of thionyl chloride into D-serine NCA in methanol, reacting at 15 ℃ for 1 hour, recovering the methanol, and adding 300mL of petroleum ether to obtain R-3-chloroserine methyl ester hydrochloride; (the obtained product R-3-chloroserine methyl ester hydrochloride had a mass of 160.92g, a purity of 99.421%, and a yield of 91.93%).
Example 2
1) Adding 126g of paraformaldehyde into 105g of D-serine in 500ml of tetrahydrofuran, reacting at room temperature for 0.5 hour, recovering tetrahydrofuran, and crystallizing to obtain D-serine NCA;
2) adding 130mL of thionyl chloride into D-serine NCA in methanol, reacting for 3 hours at 20 ℃, recovering the methanol, and adding 300mL of petroleum ether to obtain R-3-chloroserine methyl ester hydrochloride; (the obtained product R-3-chloroserine methyl ester hydrochloride has the mass of 166.87g, the purity of 99.488% and the yield of 93.11%).
Example 3
1) Adding 135g of paraformaldehyde into 105g of D-serine in 500ml of tetrahydrofuran, reacting at room temperature for 3 hours, recovering tetrahydrofuran, and crystallizing to obtain D-serine NCA;
2) adding 145mL of thionyl chloride into the D-serine NCA in methanol, reacting for 2 hours at 25 ℃, recovering the methanol, and adding 300mL of petroleum ether to obtain R-3-chloroserine methyl ester hydrochloride; (the obtained product R-3-chloroserine methyl ester hydrochloride had a mass of 165.63g, a purity of 99.526% and a yield of 94.72%).

Claims (4)

1. A synthetic method of R-3-chloroserine methyl ester hydrochloride is characterized by comprising the following steps:
1) synthesis of D-serine-N-carboxyanhydride: adding polyformaldehyde into D-serine, reacting at room temperature for 0.5-3 hours, recovering the solvent, and crystallizing to obtain D-serine-N-carboxyl anhydride;
2) synthesis of R-3-chloroserine methyl ester hydrochloride: adding D-serine NCA into a solvent, adding thionyl chloride, reacting at 15-25 ℃ for 1-3 hours, recovering the solvent, and adding petroleum ether for crystallization to obtain R-3-chloroserine methyl ester hydrochloride, wherein the solvent is methanol.
2. The method for synthesizing R-3-chloroserine methyl ester hydrochloride according to claim 1, wherein the molar ratio of D-serine to paraformaldehyde in the reaction is 1: 1.2-1.5.
3. The method for synthesizing R-3-chloroserine methyl ester hydrochloride according to claim 1, characterized in that the molar ratio of D-serine NCA to thionyl chloride to petroleum ether in the reaction is 1: 1.5-2.0: 1.
4. the method for synthesizing R-3-chloroserine methyl ester hydrochloride according to claim 1, characterized in that the solvent in step 1) is anhydrous tetrahydrofuran or dichloromethane.
CN201811613850.3A 2018-12-27 2018-12-27 Synthetic method of R-3-chloroserine methyl ester hydrochloride Active CN109678739B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201811613850.3A CN109678739B (en) 2018-12-27 2018-12-27 Synthetic method of R-3-chloroserine methyl ester hydrochloride
PCT/CN2019/103059 WO2020134137A1 (en) 2018-12-27 2019-08-28 Method for synthesizing r-3-chloroalanine methyl ester hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811613850.3A CN109678739B (en) 2018-12-27 2018-12-27 Synthetic method of R-3-chloroserine methyl ester hydrochloride

Publications (2)

Publication Number Publication Date
CN109678739A CN109678739A (en) 2019-04-26
CN109678739B true CN109678739B (en) 2020-05-05

Family

ID=66190633

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811613850.3A Active CN109678739B (en) 2018-12-27 2018-12-27 Synthetic method of R-3-chloroserine methyl ester hydrochloride

Country Status (2)

Country Link
CN (1) CN109678739B (en)
WO (1) WO2020134137A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590587A (en) * 2019-09-23 2019-12-20 湖北宇阳药业有限公司 Synthetic method of 3-chloro-L-alanine methyl ester hydrochloride
CN110606811B (en) * 2019-09-23 2022-12-02 湖北宇阳药业有限公司 Synthetic method of L-serine methyl ester hydrochloride

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3936469A (en) * 1972-11-13 1976-02-03 Kyowa Hakko Kogyo Kabushiki Kaisha Process for preparing N-carboxylic anhydrides of amino acids
CN104003894A (en) * 2013-02-21 2014-08-27 浙江嘉华化工有限公司 Method for preparing N-acetyl-beta-chlorine-L-alanine methyl ester

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106518694A (en) * 2016-10-24 2017-03-22 浙江金伯士药业有限公司 Novel preparation method of L-alanine isopropyl ester hydrochloride
CN106518695A (en) * 2016-11-03 2017-03-22 安徽省诚联医药科技有限公司 A synthetic method of (R)-methyl 2-amino-3-chloropropanoate hydrochloride

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3936469A (en) * 1972-11-13 1976-02-03 Kyowa Hakko Kogyo Kabushiki Kaisha Process for preparing N-carboxylic anhydrides of amino acids
CN104003894A (en) * 2013-02-21 2014-08-27 浙江嘉华化工有限公司 Method for preparing N-acetyl-beta-chlorine-L-alanine methyl ester

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Reaction of phosgene with serine and ethanolamine;Lapidot, Y.等;《Israel Journal of Chemistry》;19681231;第6卷(第2期);147-50页 *

Also Published As

Publication number Publication date
CN109678739A (en) 2019-04-26
WO2020134137A1 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
CN109678739B (en) Synthetic method of R-3-chloroserine methyl ester hydrochloride
KR20210120157A (en) Preparation method of artificially synthesized racemic nicotine and its salt
CN105063120B (en) A kind of preparation method of Levetiracetam
US20230045135A1 (en) Tedizolid intermediate and efficient preparation method thereof
CN107337634B (en) A kind of preparation method of Abbe Seeley midbody compound
CN102260721A (en) Process for preparing (S)-2-aminobutanamide by using enzyme method
CN101979376B (en) Method for preparing glycinamide hydrochloride
CN103451259A (en) Method for enzymatic synthesis of cefprozil in recyclable aqueous two-phase system by using immobilized penicillin acylase
CN101333175A (en) Method for preparing D-asparagine and D-homoserine
CN116621810A (en) Process for preparing 2-methyl nicotine
EP4140993A1 (en) Efficient preparation method for tedizolid intermediate, and intermediate
CN101125878B (en) Method for preparing steroid muscle relaxants rocuronium bromide
CN106636241B (en) Method for preparing esmollin intermediate by enzyme method
CN113512024B (en) Synthesis process for preparing halofuginone hydrobromide as raw material medicine for animals
CN109734680B (en) Method for synthesizing D-cycloserine
CN110684028B (en) Preparation method of 2, 6-diazabicyclo [3,3,0] octane compound
CN110804022B (en) Preparation method of dexrazoxane
CN108129430A (en) A kind of synthetic method of Li Tasite intermediates
CN110015969A (en) A kind of synthetic method of Linezolid impurity
CN105198825B (en) A kind of preparation method of D seromycins
CN110551129B (en) Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester
CN113801009B (en) Method for catalyzing gallic acid methylation by using ionic liquid
CN103435501B (en) A kind of Salt formation crystallization method of ethambutol hydrochloride
JPH0827072A (en) Production of 2-methyl-1,2-propanediamine
CN109516924B (en) Method for preparing m-aminophenol by catalyzing resorcinol

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: Room 2708, 27th floor, No. 4 Huixin East Street, Chaoyang District, Beijing

Applicant after: Beijing Fusheng Jiahua Pharmaceutical Technology Co., Ltd.

Address before: Room 2708, 27th floor, No. 4 Huixin East Street, Chaoyang District, Beijing

Applicant before: Beijing Fusheng Jiahua International Trade Co., Ltd.

GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Liu Lili

Inventor after: Yuan Zhifa

Inventor after: Wang Dan

Inventor after: Yang Wen

Inventor after: Li Jun

Inventor after: Zhang Xinwei

Inventor before: Wang Dan

Inventor before: Yang Wen

Inventor before: Li Jun

Inventor before: Zhang Xinwei

Inventor before: Liu Lili

Inventor before: Yuan Zhifa